GlassScriptPhysician profile
Kerry Zang
NPI 1558331462
$111,041.04
in general payments reported to CMS, 2019-2025
14 companies · $3,386 in 2025
The $3,386 reported for 2025 was more than what 94% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41K · 2020: $31K · 2021: $23K · 2022: $5,350 · 2023: $5,098 · 2024: $1,871 · 2025: $3,386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $10K · Food and Beverage: $92.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $10,261.72 |
| Food and Beverage | $92.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osteomed LLC | $99,816.21 | 2019-2022 | |
| Acumed LLC | $10,261.72 | 2023-2025 | Osteomed |
| Musculoskeletal Transplant Foundation INC. | $591.05 | 2020 | |
| Medtronic Vascular, INC. | $129.10 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $55.86 | 2021-2023 | Jublia |
| Orthofix Medical, INC. | $40.36 | 2019-2023 | Physio-Stim |
| Wright Medical Technology, INC. | $36.95 | 2019 | |
| Abbott Laboratories | $19.91 | 2023 | Proclaim |
| Sirtex Medical INC | $18.78 | 2024 | Sir-Spheres Microspheres |
| Ibsa Pharma INC. | $18.42 | 2024 | Tirosint, Licart |
| Smith+Nephew, INC. | $16.12 | 2020 | |
| Misonix INC | $14.47 | 2021 | |
| Aap Implants INC | $11.25 | 2022 | |
| Bioventus LLC | $10.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kerry Zang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.